Bioxcel Therapeutics Inc (BTAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 457 | 206 | 238 | 137 | 0 |
| Cost of Goods | 26 | 9 | 9 | 11 | N/A |
| Gross Profit | 431 | 197 | 229 | 126 | N/A |
| Operating Expenses | 52,871 | 51,404 | 53,125 | 39,127 | 36,288 |
| Operating Income | -52,414 | -51,198 | -52,887 | -38,990 | -36,288 |
| Interest Expense | 3,259 | 3,367 | 2,920 | 3,700 | 1,586 |
| Other Income | 2,158 | 1,769 | 997 | 885 | 204 |
| Pre-tax Income | -53,515 | -52,796 | -54,810 | -41,805 | -37,670 |
| Net Income Continuous | -53,515 | -52,796 | -54,810 | -41,805 | -37,670 |
| Net Income | $-53,515 | $-52,796 | $-54,810 | $-41,805 | $-37,670 |
| EPS Basic Total Ops | -29.28 | -29.44 | -31.36 | -23.84 | -21.60 |
| EPS Basic Continuous Ops | -29.34 | -29.52 | -31.27 | -23.87 | -21.53 |
| EPS Diluted Total Ops | -29.28 | -29.44 | -31.36 | -23.84 | -21.60 |
| EPS Diluted Continuous Ops | -29.34 | -29.52 | -31.27 | -23.87 | -21.53 |
| EBITDA(a) | $-52,333 | $-51,118 | $-52,806 | $-38,905 | $-36,204 |